Investigation of community carriage rates of Clostridium difficile and Hungatella hathewayi in healthy volunteers from four regions of England.

[1]  B. Lissoir,et al.  A Clostridium hathewayi isolate in blood culture of a patient with an acute appendicitis. , 2015, Anaerobe.

[2]  K. Suresh,et al.  Hungatella effluvii gen. nov., sp. nov., an obligately anaerobic bacterium isolated from an effluent treatment plant, and reclassification of Clostridium hathewayi as Hungatella hathewayi gen. nov., comb. nov. , 2014, International journal of systematic and evolutionary microbiology.

[3]  C. Eckert,et al.  Evaluation of the Chromogenic Agar chromID C. difficile , 2012, Journal of Clinical Microbiology.

[4]  C. Hill,et al.  Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota , 2011, Journal of Clinical Microbiology.

[5]  N. Beeching,et al.  Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom , 2011, PloS one.

[6]  Laura C Rodrigues,et al.  Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice , 2011, Gut.

[7]  M. Rupnik,et al.  Use of Modified PCR Ribotyping for Direct Detection of Clostridium difficile Ribotypes in Stool Samples , 2011, Journal of Clinical Microbiology.

[8]  M. Wilcox,et al.  A case-control study of community-associated Clostridium difficile infection. , 2008, The Journal of antimicrobial chemotherapy.

[9]  Laura C Rodrigues,et al.  Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance , 1999, BMJ.

[10]  J. Bartlett,et al.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.

[11]  Laura C Rodrigues,et al.  Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice , 2022 .